PUBLISHER: The Insight Partners | PRODUCT CODE: 1872749
PUBLISHER: The Insight Partners | PRODUCT CODE: 1872749
The cold laser therapy market size was valued at US$ 356.33 million in 2024 to US$ 562.62 million by 2031; it is anticipated to record a CAGR of 6.90% during 2025-2031.
Key factor driving the market growth are the growing prevalence of chronic pain conditions such as orthopedic disorders and utilization of cold laser in dermatology propel the cold laser therapy market growth. However, high treatment costs hamper the growth of the market.
Market Drivers of the Cold Laser Therapy Market
Cold laser therapy has diverse applications across multiple healthcare domains, spanning pain management, orthopedics, dermatology, and dentistry. Due to the rising prevalence of orthopedic conditions such as arthritis, musculoskeletal injuries, neuropathic pain, and chronic injuries, the utilization of cold laser therapy in healthcare institutions and homecare settings has increased. According to the data published by the World Health Organization (WHO), in February 2021, ~1.71 billion individuals worldwide suffered from musculoskeletal problems, with lower back pain being the most widespread musculoskeletal condition, affecting 568 million people globally. Cold laser therapy is a noninvasive and effective treatment to alleviate chronic back pain. A study, "Effectiveness of Low-Level Laser Therapy in Patients with Discogenic Lumbar Radiculopathy," published by Hindawi in February 2022, was carried out with 110 patients suffering from acute lower back pain and unilateral discogenic lumbar radiculopathy. Of the total patients, 55 patients were treated with LLLT combined with conventional physical therapy, while the other control group of 55 patients was treated with only conventional physical therapy. The study demonstrated that LLLT, as an adjunct therapy to conventional physical therapy, significantly improved local trunk movements, pain intensity, and related functional disability, as compared with conventional physical therapy alone in the treatment of discogenic lumbar radiculopathy.
Additionally, cold laser therapy is employed in dermatology and aesthetic medicine for noninvasive skin rejuvenation, anti-aging treatment, and improvement of skin texture. The most successful commercial use of LLLT is in managing androgenetic alopecia (AGA) for both men and women. A study, "Efficacy Assessment for Low-Level Laser Therapy in the Treatment of Androgenetic Alopecia," published by Springer Link in February 2022, was carried out on 1,383 patients using Food and Drug Administration (FDA)-cleared iHelmet (Slinph Technologies Co., Ltd, Shenzhen, China). The study showed that treatment with LLLT helmets was moderately effective for 51.9% of users with mild AGA and 57.4% with moderate-to-severe AGA. Therefore, the abovementioned factors contribute to the growing utilization of cold laser devices as a therapeutic modality in modern healthcare settings and are responsible for the cold laser therapy market growth.
Cold Laser Therapy Market: Segmental Overview
The cold laser therapy market, by product, is segmented into instruments and accessories. The instruments segment held the larger cold laser therapy market share in 2024 and is anticipated to register the higher CAGR during 2024-2031.
The cold laser therapy market, by application, is segmented into orthopedics, dermatology, neurology and others. The orthopedics segment is expected to hold the largest market share in 2024.
The market, by end user, is segmented into hospitals, specialty clinics, homecare settings, and others. In 2022, the hospital segment held the largest share of the market The specialty clinics segment is anticipated to register the highest CAGR during 2024-2031. Specialty clinics frequently concentrate on certain ailments, such as pain treatment, sports injuries, physiotherapy, dermatology, or dentistry, all of which are important fields in which cold laser therapy finds use. This approach increases patient happiness and trust by enabling clinics to use cold laser equipment to provide better results and develop deeper expertise. Cold laser therapy is frequently combined with physiotherapy, chiropractic adjustments, acupuncture, or skincare procedures in specialty clinics. In addition to improving therapeutic effectiveness, this complementary strategy aids clinics in setting themselves apart from regular hospitals.
Cold Laser Therapy Market: Geographical Overview
Based on geography, the market is segmented into North America, Asia Pacific, Europe, the Middle East & Africa, and South & Central America. In terms of revenue, North America dominated the cold laser therapy market share in 2024. Asia Pacific is expected to register the fastest CAGR in the cold laser therapy market during the forecast period.
In 2022, North America held the largest global market share and is estimated to continue its dominance from 2022 to 2030. The US held the largest market share in the region in 2022, followed by Canada. According to by US Office of Disease Prevention and Health Promotion, the prevalence of arthritis is expected to rise to 78.4 million by 2040 due to aging and other population trends such as obesity. The US has a high prevalence of orthopedic diseases and musculoskeletal injuries, which expand the cold laser therapy market share in the region. According to the Canadian Journal of Health Technologies, in 2022, ~8 million people in Canada live with chronic pain and 80% of adults experience chronic low back pain at least once during their lifetime. These individuals face various challenges impacting their social, physical, mental, and professional aspects on a daily basis. The availability of innovative cold laser devices such as Erchonia FX 635, well-developed healthcare infrastructure, and the rising adoption of advanced laser therapy technologies are expected to fuel the regional market growth during 2024-2031.